ENTRY       D10919                      Drug
NAME        Cosfroviximab (USAN/INN)
SEQUENCE    (Heavy chain)
            DVKLLESGGG LVQPGGSLKL SCAASGFSLS TSGVGVGWFR QPSGKGLEWL ALIWWDDDKY
            YNPSLKSQLS ISKDFSRNQV FLKISNVDIA DTATYYCARR DPFGYDNAMG YWGQGTSVTV
            SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
            SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKRV EPKSCDKTHT CPPCPAPELL
            GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
            YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR
            DELTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS
            RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
            (Light chain)
            DIVMTQSPLS LSTSVGDRVS LTCKASQNVG TAVAWYQQKP GQSPKLLIYS ASNRYTGVPD
            RFTGSGSGTD FTLTISNMQS EDLADYFCQQ YSSYPLTFGA GTKLELRTVA APSVFIFPPS
            DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
            SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
            (Disulfide bridge: H22-H97, H149-H205, H225-L213, H231-H'231, H234-H'234, H266-H326, H372-H430, H'22-H'97, H'149-H'205, H'225-L'213, H'266-H'326, H'372-H'430, L23-L88, L133-L193, L'23-L'88, L'133-L'193)
  TYPE      Peptide
EFFICACY    Antiviral
  TYPE      Monoclonal antibody
COMMENT     Treatment of Ebola virus
TARGET      Ebolavirus envelope glycoprotein [KO:K24534]
  PATHWAY   ko03230(K24534)  Viral genome structure
BRITE       Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Ebolavirus glycoprotein
                D10919  Cosfroviximab (USAN/INN)
DBLINKS     CAS: 1792982-57-0
            PubChem: 342581776
///
